National Research (NASDAQ:NRC) Share Price Passes Above Two Hundred Day Moving Average - Here's Why

Key Points

• National Research Corporation's stock price has recently crossed above its 200-day moving average, trading at $16.20 after reaching a high of $16.46.
• The company reported a net margin of 12.78% and a return on equity of 83.52% in its latest quarterly earnings, with revenue of $34.04 million.
• National Research announced a quarterly dividend of $0.12 to be paid on October 10th, resulting in an annualized dividend of $0.48 and a dividend yield of 3.0%.

National Research Corporation (NASDAQ:NRC - Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $14.26 and traded as high as $16.46. National Research shares last traded at $16.20, with a volume of 99,835 shares changing hands.

National Research Stock Down 6.9%

The company has a debt-to-equity ratio of 3.61, a quick ratio of 0.70 and a current ratio of 0.70. The stock's fifty day simple moving average is $14.90 and its two-hundred day simple moving average is $14.30. The company has a market capitalization of $341.29 million, a price-to-earnings ratio of 19.47 and a beta of 0.47.

National Research (NASDAQ:NRC - Get Free Report) last released its earnings results on Monday, July 28th. The company reported $0.28 EPS for the quarter. The business had revenue of $34.04 million for the quarter. National Research had a net margin of 12.78% and a return on equity of 83.52%.

National Research Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 3.2%. The ex-dividend date of this dividend is Friday, September 26th. National Research's dividend payout ratio is currently 63.16%.

Institutional Trading of National Research

Institutional investors and hedge funds have recently bought and sold shares of the stock. EverSource Wealth Advisors LLC raised its holdings in National Research by 9,535.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company's stock worth $28,000 after buying an additional 1,621 shares during the period. Strs Ohio purchased a new position in shares of National Research in the first quarter worth approximately $33,000. Raymond James Financial Inc. acquired a new position in National Research in the 2nd quarter worth approximately $34,000. PNC Financial Services Group Inc. boosted its stake in National Research by 1,072.5% in the 2nd quarter. PNC Financial Services Group Inc. now owns 2,087 shares of the company's stock worth $35,000 after purchasing an additional 1,909 shares during the period. Finally, Aviso Financial Inc. boosted its stake in National Research by 37.2% in the 1st quarter. Aviso Financial Inc. now owns 3,076 shares of the company's stock worth $39,000 after purchasing an additional 834 shares during the period. Institutional investors and hedge funds own 47.26% of the company's stock.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.